• About us
    • About us
    • Mission & Vision
    • History
  • Technology
    • NAVI system
    • VLP platform
  • Pipeline
    • Animal Disease Vaccines
    • Zoonotic Vaccines
    • Adjuvants
  • Product
    • Nanobodys
    • Gene Stocks
    • Recombinant Protein
  • Community
    • Notice
    • News
    • Careers
    • Location
  • KR
  • EN
사이트맵 보기

SITE MAP

  • About us
    • About us
    • Mission & Vision
    • History
  • Technology
    • NAVI system
    • VLP platform
  • Pipeline
    • Animal Disease Vaccines
    • Zoonotic Vaccines
    • Adjuvants
  • Product
    • Nanobodys
    • Gene Stocks
    • Recombinant Protein
  • Community
    • Notice
    • News
    • Careers
    • Location

Technology

NAVI system

  • NAVI system
  • VLP platform

Nanovax Core Technology

We offer advanced life science research capabilities
by integrating core technologies in synthetic biology, biotechnology, and immunology
enabling the development of novel therapeutics and next-generation vaccine technologies.

NAVI (New Age Vaccine for Infection) System

  • 1 Recombinant Genetic Engineering Technology

    Gene Cloning Gene Synthesis Gene Optimization/Deoptimization

  • 2 Protein Expression Technology

    E.coli Expression System Baculovirus Expression System Mammalian Cell Expression System

  • 3 Protein Purification Technology

    Ni-NTA/Co-NTA column purification Column Chromatography Gradient density centrifugation

  • 4 Bioactivity Analysis Technology

    Preclinical Animal Study ELISA Analysis HA/HI Analysis

  • 5 Synthetic Biology Technology

    Establishment of Stable Cell Lines Adenovirus / Lentivirus Production MTT / EMSA Analysis

  • 6 Cell Culture Technology

    Construction of Optimized Expression Vectors Establishment of High-Expression (High-Yield) Cell Lines Development of Optimized Culture Conditions

Benefit of NAVI system

  • Selectivity

    Multi-vector
    combination
  • Production

    Mass production in
    E.coli/Insect cell
  • Culture

    Optimized
    culture condition
  • Potency

    Over the
    current Vaccine
  • Next-Gen
    Vaccine
    Technology

    Novel vaccine development and production capacity for pandemic
로고 이미지

nanovax #1003, #1004, #1010, #1011, 282 Sunhwagung-ro, Namyangju-si, Gyeonggi-do TEL. 031-572-6886 EMAIL. nanovax@nanovax.co.kr

COPYRIGHT ⓒ 2025 NANOVAX co.,ltd. ALL RIGHTS RESERVED.